IMMVARX INC has a total of 17 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are HONSHIYO YUU, APPLIED GENETIC TECH CORP and JAIN ARJUN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EAPO (Eurasian Patent Organization) | 1 | |
#7 | Hong Kong | 1 | |
#8 | Japan | 1 | |
#9 | Mexico | 1 | |
#10 | New Zealand | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Electrical machinery and energy |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Sugars | |
#4 | Microorganisms | |
#5 | Medical preparations | |
#6 | Magnets and transformers |
# | Name | Total Patents |
---|---|---|
#1 | Radosevich James A | 8 |
#2 | Babich Michael | 3 |
#3 | Radosevich James | 2 |
#4 | Immvarx Inc | 1 |
#5 | Michael Babich | 1 |
#6 | O'Steen Steven Bryan | 1 |
#7 | Morris Arthur Sherman | 1 |
#8 | James Radosevich | 1 |
Publication | Filing date | Title |
---|---|---|
AU2008202039A1 | Gene encoding labyrinthin, a marker for cancer | |
EP1370286A1 | Compositions of multimeric profilin for diagnosis and treatment of allergies | |
US6166176A | Cancer marker protein and peptides thereof |